NSAID Reference List
January 20, 2005 15:57

1 T Towheed, B Shea, G Wells, M Hochberg. Osteoarthritis: a systematic review of randomized controlled trials of analgesia and anti-inflammatory therapy in osteoarthritis of the hip. Cochrane Library 1997, issue 4. 2 Other Cochrane reference. 3 KIM Antonov, DGL Isacson. Prescription and nonprescription analgesic use in Sweden. Annals of Pharmacotherapy 1998 32: 485-94. 4 R Tamblyn, L Berkson, WD Dauphinee et al. Unnecessary prescribing of NSAIDs and the management of NSAID-related gastropathy in medical practice. Annals of Internal Medicine 1997 127: 429-38. 5 AL Blower, A Brooks, CG Fenn et al. Emergency admissions for upper gastrointestinal disease and their relation to NSAID use. Aliment Pharmacol Ther 1997 11: 283-91. 6 CJ Hawkey, DJ Cullen, DC Greenwood et al. Prescribing of nonsteroidal anti-inflammatory drugs in general practice: determinants and consequences. Aliment Pharmacol Ther 1997 11: 293-8. 7 TM MacDonald, SV Morant, GC Robinson et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. British Medical Journal 1997 315: 1333-7. 8 RA Moore, CJ Phillips. Cost of NSAID adverse effects to the UK National Health Service. Journal of Medical Economics 1999 2: 45-55. 9 Koch M, Dezi A, Ferrario F, Capurso L. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. Archives of Internal Medicine 1996 156: 2321-32. 10 FE Silverstein, DY Graham, JR Senior et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Annals of Internal Medicine 1995 123: 241-9. 11 D Henry, A Dobson, C Turner. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993 105: 1078-88. 12 D Henry, L Lim, L Garcia Rodriguez et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. British Medical Journal 1996 312: 1563-6. 13 LA Garcia Rodriguez et al. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Archives of Internal Medicine 1998 158: 33-39. 14 CJ Hawkey, JA Karrasch, L Szczepanki et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. New England Journal of Medicine 1998 338: 727-34. 15 ND Yeomans, Z Tulassay, L Juhasz et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. New England Journal of Medicine 1998 338: 791-26. 16 FK Chan, JJ Sung, SC Chung et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997 350: 975-9. 17 G Singh. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. American Journal of Medicine 1998 105(1B): 31S-38S. 18 JMM Evans, A McMahon , M McGilchrist et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. British Medical Journal 1995 311: 22-6. 19 RA Moore, D Carroll, PJ Wiffen, M Tram?, HJ McQuay. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. British Medical Journal 1998 316: 333-8.... http://www.jr2.ox.ac.uk/bandolier/booth/painpag/nsae/nsae.html#Heading21

Health Canada is warning people about heart and skin problems associated with the painkiller Bextra.
• Many patients switched to Bextra after Vioxx was pulled from shelves.
• A recent clinical trial found patients who took Bextra for pain after coronary artery bypass graft surgery experienced heart attacks or strokes, blood clots in the legs or lungs and infections or other complications.
• Bextra's manufacturer, Pfizer, is planning long-term studies on the cardiovascular safety of Bextra for arthritis patients.